Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Cash from Financing Activities (2016 - 2023)

Pulmatrix (PULM) has disclosed Cash from Financing Activities for 11 consecutive years, with $53000.0 as the latest value for Q1 2023.

  • Quarterly Cash from Financing Activities rose 134.87% to $53000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $53000.0 through Dec 2023, down 95.69% year-over-year, with the annual reading at $53000.0 for FY2023, 95.69% down from the prior year.
  • Cash from Financing Activities hit $53000.0 in Q1 2023 for Pulmatrix, down from $1.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $37.3 million in Q1 2021 to a low of -$152000.0 in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $7.0 million across 5 years, with a median of $2.2 million in 2019.
  • Biggest five-year swings in Cash from Financing Activities: surged 321600.0% in 2020 and later plummeted 100.41% in 2022.
  • Year by year, Cash from Financing Activities stood at $3000.0 in 2019, then surged by 428833.33% to $12.9 million in 2020, then crashed by 51.88% to $6.2 million in 2021, then tumbled by 77.68% to $1.4 million in 2022, then plummeted by 96.16% to $53000.0 in 2023.
  • Business Quant data shows Cash from Financing Activities for PULM at $53000.0 in Q1 2023, $1.4 million in Q3 2022, and -$152000.0 in Q1 2022.